Akèy › Metiyè › Molecular and Cellular Biologists › Woburn, MA
Molecular and Cellular Biologists nan Woburn, MA: Salè H-1B
22 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Woburn, MA. Salè baz medyàn ofri $92,800; mwatye mitan $83,750–$114,750.
Demann (LCA)22
Salè medyan ofri$92,800
Mwatye salè yo$83,750–$114,750
10yèm–90yèm pousantaj$77,616–$136,821
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $80,000 |
| Nivo II (kalifye) | $92,000 |
| Nivo III (eksperyans) | $114,000 |
| Nivo IV (plen kompetans) | $190,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Replimune Inc. | 4 | $126,000 |
| Spear Bio Inc. | 4 | $88,500 |
| Javelin Biotech, Inc. | 3 | $90,000 |
| Revival Bio, Inc. | 3 | $66,560 |
| United Pharma Technologies, Inc. | 1 | $93,600 |
| General Hospital Corporation | 1 | $70,000 |
| Microbial Machines, Inc. | 1 | $111,238 |
| Orogen Therapeutics, Inc. | 1 | $120,000 |
| Vaxess Technologies, Inc. | 1 | $106,000 |
| Leveragen, Inc. | 1 | $114,000 |
| ABclonal Science Inc. | 1 | $78,462 |
| inov8.bio Inc. | 1 | $190,000 |
Tit travay
- Stem Cell Biologist3
- Research Associate2
- Associate Scientist2
- Lead Clinical Data Manager1
- Scientist, Analytical Development1
- Clinical Trail Associate1
- Quality Control Associate II1
- Data Scientist1
- Health Data Analyst II1
- Clinical Project Manager, Clinical Operations1
- Scientist1
- Machine Learning Engineer1
- Bioinformatics Scientist1
- Senior Principal Research Scientist1
- Scientist II1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).